Why Pressure Ulcer Prevention Is Becoming a Strategic Health-Care Market in Eurasia

Executive Summary

Pressure ulcer prevention has evolved from a niche clinical concern into a distinct medical device and care management market. Global market valuations point to steady growth — from USD 1.20 billion in 2025 to an anticipated USD 1.80 billion by 2034 — driven by aging populations, rising rates of immobility-related chronic conditions, and greater hospital focus on patient safety and value-based care. For Eurasia, a region characterized by diverse health-care systems, demographic pressures, and growing medical infrastructure, this market carries emerging strategic importance. This article assesses the pressure ulcer prevention market's growth drivers, regional dynamics, and implications for business strategy, cross-border trade, and investment across Europe, Central Asia, the Caucasus, and Türkiye.

Introduction

Pressure ulcers — also known as bedsores — are preventable tissue injuries caused by prolonged pressure, shear, friction, or moisture. They impose significant clinical, economic, and operational burdens on health-care systems. The global pressure ulcer prevention market includes static and dynamic support surfaces, dressings, positioners, creams, and increasingly sensor-based digital monitoring solutions. In Eurasia, where public health systems are under pressure from demographic aging and chronic disease prevalence, the market is becoming a point of focus for medical device manufacturers, hospital administrators, and health policymakers.

Main Analysis

Market Fundamentals and Growth Trajectory

According to market research published by Fortune Business Insights, the pressure ulcer prevention market was valued at USD 1.20 billion in 2025 and is projected to reach USD 1.80 billion by 2034, reflecting a compound annual growth rate (CAGR) of 4.6% from 2026 to 2034. North America remains the largest market, with Europe following as the second-largest regional segment, projected to grow at a CAGR of 3.7%. The Asia Pacific region — which includes parts of Central Asia and the Russian Far East — is expected to become the third-largest market by 2026.

The ageing population is a primary driver. In Europe and Central Asia, the share of people aged 65 and above continues to rise, increasing the incidence of chronic diseases such as diabetes, COPD, and renal failure that lead to prolonged hospitalization and immobility. This trend aligns with the market's emphasis on preventive rather than reactive care — a shift that reduces long-term costs and improves patient outcomes. Additionally, hospitals across the region are adopting pressure ulcer prevention programs as part of broader patient safety protocols and quality reporting frameworks, such as those promoted by the World Health Organization and, in the EU, the European Quality of Care and Patient Safety initiatives.

Key Players and Competitive Landscape

The 2025 market was led by established global players — Baxter, Arjo, Stryker, Medline, and Mölnlycke — which together held the largest share. These companies have built advantages through broad product portfolios, brand recognition, and long-standing relationships with health-care institutions. In Eurasia, the presence of these multinationals is pronounced in Western Europe, while domestic players in Türkiye, Poland, and Russia are increasingly supplying lower-cost foam surfaces and basic support products. The competitive landscape is being reshaped by technological innovation, particularly the integration of sensors and data analytics into support surfaces, enabling real-time monitoring of patient repositioning. This digital shift is opening opportunities for Eurasian software companies and medical device start-ups to enter the market through partnerships rather than full-scale manufacturing.

Emerging Trends and Technology Adoption

A significant trend is the growing utilization of multi-layer silicone foam dressings as a preventive measure, applied proactively to high-risk areas like the sacrum, heels, and elbows. Their cushioning and atraumatic removal properties make them especially suitable for intensive care units, operating rooms, and elderly care settings. In Eurasian markets, this trend is being accelerated by procurement standardization in Western European hospitals and by the expansion of private health-care groups in Türkiye and the Gulf-adjacent Caucasus region.

Another trend is the rise of smart, sensor-based prevention systems. These devices use algorithms to alert nursing staff when a patient requires repositioning, thereby reducing the reliance on manual protocols. The penetration of such digital solutions is uneven across Eurasia: advanced in Germany, Nordic countries, and the UK, but nascent in Central Asia and the Western Balkans. This gap presents a market access opportunity for distributors and investors who can bridge the digital divide through mobile-based applications and low-cost sensor hardware.

Restraints and Market Frictions

Despite growth, the market faces constraints. The high cost of advanced support surfaces and digital monitoring systems limits adoption, particularly in emerging economies within Eurasia. In countries such as Uzbekistan, Georgia, and Albania, health-care budgets prioritize acute care over preventive technologies, leading to a preference for economical foam mattresses and manual repositioning protocols. Inconsistent reimbursement frameworks across EU member states and the broader Caucasus further complicate market expansion. For instance, while Germany has robust coverage for dynamic support surfaces, many Central Asian health systems lack formal reimbursement codes for preventive products, forcing patients to bear the cost themselves.

The cost burden was highlighted in a 2021 NCBI cohort study cited in the reference, which estimated the cost of a single wearable sensor at around USD 39,580 over a 52-week period — a figure that underscores the economic barrier to widespread digital adoption. Such high entry costs create a two-tier market: high-tech solutions in affluent urban centers, and basic prevention in rural and lower-income regions.

Business Impact

For medical device manufacturers and distributors operating in Eurasia, the pressure ulcer prevention market offers several strategic implications.

Portfolio rationalization: Multinationals need to tailor product lines to different purchasing power segments. In Western Europe, growth will come from premium smart support surfaces and clinically-proven dressings. In Eastern Europe and Central Asia, cost-effective alternatives with reliable supply chains will capture market share.
Supply chain resilience: The disruption of global logistics following recent geopolitical shocks has prompted regional manufacturers to localize production of foam, gel, and non-woven materials. Türkiye and Poland are emerging as production bases, leveraging lower labor costs and proximity to both EU and Middle Eastern markets.
Digital health integration: Investment in sensor technologies and cloud-based monitoring platforms can differentiate offerings. Partnerships with Eurasian IT companies can reduce development costs and comply with local data residency requirements.
Distribution channels: Homecare settings are expanding across Eurasia as governments shift to outpatient and home-based care models. Companies that build channels through medical supply distributors, pharmacies, and direct-to-patient platforms will be well positioned.

Regional Perspective

The pressure ulcer prevention market interacts differently with each subregion of Eurasia.

European Union: The EU is the largest and most mature market in the region. Its aging demographics and strong health-care infrastructure drive demand for advanced support surfaces and digital monitoring. Harmonized medical device regulations (MDR) raise compliance costs, but also create barriers to entry that favor established players. The EU's focus on sustainable health-care may also push demand for recyclable and reusable prevention products.
Türkiye: As a major manufacturing hub, Türkiye exports medical textiles and foam products to Europe, the Middle East, and Central Asia. Its companies are expanding from low-cost production into higher-value-added products such as alternating-pressure mattresses. Government investment in hospital infrastructure, including PPP models, is increasing the installed base of support surfaces.
Central Asia (Kazakhstan, Uzbekistan, etc.): Rapid economic growth and increasing health-care budgets are creating demand for basic prevention products. However, the lack of specialized clinical protocols and trained staff limits uptake. International health organizations, such as WHO and UNICEF, are involved in facility upgrades, which may incorporate pressure ulcer prevention standards.
Caucasus and Western Balkans: These emerging markets face mixed prospects. Georgia's health-care reform has stimulated private hospital investment, while Serbia is strengthening its domestic medical device industry. Cross-border trade in medical supplies is growing, but regulatory harmonization with the EU remains an obstacle.
Caspian region: The energy-rich states of Azerbaijan and Kazakhstan are investing in modern hospitals but tend to import high-end products. For suppliers, long-term contracts with state procurement agencies offer stable revenues, but require navigating complex tender processes.

Future Outlook (2026–2034)

The next three to five years will be formative for the pressure ulcer prevention market in Eurasia.

Market growth: The global CAGR of 4.6% is expected to be mirrored or slightly exceeded in Eurasia, with Central and Eastern Europe growing faster than Western Europe due to lower baseline adoption. By 2034, Europe's market size could approach USD 0.5 billion, while combined Eurasian non-EU markets (Türkiye, Central Asia, Caucasus) may add USD 0.2–0.3 billion.
Technology adoption: Sensor-integrated support surfaces will move from premium to standard in high-income health systems, driven by cost-reduction in electronics. Artificial intelligence algorithms will improve pressure injury prediction based on electronic health records and patient movement data. This will create synergies with the broader digital economy, where Eurasian IT hubs such as Tallinn, Warsaw, and Yerevan are already strong.
Regulatory convergence: The EU MDR and potential alignment in neighboring countries (e.g., Türkiye's CE recognition, Georgia's association agreements) will reduce trade barriers. Companies that achieve compliance early will gain regional market access.
Investment opportunities: Private equity and infrastructure funds will increasingly target pressure ulcer prevention as part of broader health-care efficiency campaigns. Public-private partnerships for hospital ward renovation and medical equipment leasing are likely to grow, especially in Central Asia.
Supply chain localization: Geopolitical fragmentation and the rise of the Middle Corridor trade route will encourage the establishment of regional production facilities. Uzbekistan and Kazakhstan are emerging as logistics hubs for medical goods, which could lower import costs and improve supply security.
Health policy emphasis: Value-based care models will gain traction in the EU and Türkiye, with reimbursement tied to patient outcomes. Pressure ulcer rates are already a quality indicator in many national health systems; prevention will thus be financially incentivized. In emerging markets, international donor programs will gradually shift from treatment to prevention, funded by development banks.

Conclusion

Pressure ulcer prevention is no longer a marginal clinical support product but a strategic segment within Eurasia's broader health-care economy. The market's steady growth, technological evolution, and regional disparities create both opportunities and challenges. Business leaders should view this not merely as a procurement category, but as a field where innovation, supply chain design, and policy engagement converge. For Eurasia, the integration of prevention practices across health systems can yield substantial long-term savings and improvements in care quality. Investors and manufacturers that recognize the region's diversity and invest accordingly — from premium digital solutions in the EU to practical, low-cost products in Central Asia — will be positioned to benefit over the coming decade.

Key Takeaways

The global pressure ulcer prevention market is forecast to reach USD 1.80 billion by 2034, growing at 4.6% CAGR.
Europe is the second-largest regional market, with Central Asia and the Caucasus representing emerging opportunities.
Aging populations, hospital patient-safety programs, and digital health innovation are the primary growth drivers.
High costs and inconsistent reimbursement remain the key constraints across much of Eurasia.
Business strategy must adapt to subregional differences in purchasing power, regulatory frameworks, and technological readiness.
Investment in localized production and sensor-based solutions will be critical to capturing long-term market share.